Mater Research

Name

Mater Research

Legal name

Mater Misericordiae Ltd

Website

https://materresearch.org.au

Company type

Private

Founded year

1910

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Medical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Medical research services
• Clinical trials
• Translational research
• Biomedical research
• Health research

Headquarters

HQ city

South Brisbane

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Government Research Grants: Primary funding from competitive government grants including NHMRC (National Health and Medical Research Council), MRFF (Medical Research Future Fund), and CRC-P (Cooperative Research Centres Projects) grants
2. Philanthropic Funding: Funding from Mater Foundation, Equity Trustees partnership program, and other charitable donors supporting research programs and researcher career development
3. Clinical Trials Revenue: Revenue from conducting industry-sponsored and investigator-initiated clinical trials through Mater Clinical Trials unit

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Mater Research is a translational medical research institute conducting biomedical and clinical research across five core programs: Cancer, Mother and Baby, Chronic and Integrated Care, Neuroscience, and Healthcare Delivery and Innovation. The institute operates clinical trials, longitudinal cohort studies, biobanks, and develops diagnostic platforms such as the AI-powered RhinoMAP. Research findings are translated into improved patient care at affiliated Mater hospitals and disseminated through peer-reviewed publications and clinical guidelines.

Product overview

Mater Research is a translational medical research institute operating as part of the Mater Group. The organization conducts research across five core programs: Cancer, Mother and Baby, Chronic and Integrated Care, Neuroscience, and Healthcare Delivery and Innovation. Research activities span diagnostic platforms (RhinoMAP), longitudinal cohort studies (Queensland Family Cohort, Strong Families Study), clinical trials, and digital health services (eConsultant). The institute maintains specialized biobanking infrastructure and partners with clinical services to translate discoveries into patient care.

Differentiator

Problem solved

Functional benefit

Products and services

• RhinoMAP
• Strong Families Study
• Queensland Family Cohort (QFC)
• Mater Clinical Trials
• Mater Research Biobank
• Inflammatory Bowel Disease Biobank
• eConsultant Program

Quantifiable outcome

• Reduced stillbirth rates through Safer Baby SEEK program implementation
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

20 partnerships are on record, tiered core, major and supporting.

• Monash UniversitycoreStrategic or Co-development PartnerCollaborating partner in CRC-P project for respiratory disease AI diagnostic platform (RhinoMAP), contributing to clinical validation and research expertise
• Diag-Nose.iocoreStrategic or Co-development PartnerAustralian health technology company leading development of AI-powered diagnostic platform for respiratory diseases, partnered with Mater Research for clinical validation
• ENT Clinic MelbournemajorStrategic or Co-development PartnerClinical partner providing otolaryngology expertise for respiratory disease diagnostic platform validation
• Manse MedicalmajorStrategic or Co-development PartnerMedical technology partner contributing to respiratory disease diagnostic platform development
• InvetechsupportingTechnology or IntegrationTechnology partner involved in diagnostic platform development and manufacturing
• Human HealthsupportingStrategic or Co-development PartnerPartner in respiratory disease AI diagnostic project
• The University of QueenslandcoreStrategic or Co-development PartnerMajor academic partner; UQ representation on Mater Research Board; Mater Clinical Unit at UQ; joint research programs and publications
• Translational Research Institute (TRI)coreStrategic or Co-development PartnerCollaborative research institute partnership; Mater secured 5 of 10 TRI LINC Grants in 2025
• Health Translation QueenslandmajorStrategic or Co-development PartnerBrisbane-wide collaborative network evolved from Diamantina Health Partners Mother and Baby Program
• Indigenous Steering CommitteecoreStrategic or Co-development Partner32 representatives from partner health services across Cairns, Mareeba, Townsville, Rockhampton, and Brisbane leading co-designed Indigenous health research
• Carbal Aboriginal Medical ServicescoreStrategic or Co-development PartnerCommunity-controlled health service in Toowoomba and Warwick co-designing research with Indigenous Health Group
• Harvard Medical SchoolmajorStrategic or Co-development PartnerInternational research collaborator on OTUD3 gene discovery for ulcerative colitis
• Mass General BrighammajorStrategic or Co-development PartnerUS collaborator on IBD genetic research; Dr Manish Gala co-author on OTUD3 study
• Monash UniversitymajorStrategic or Co-development PartnerAustralian collaborator on ulcerative colitis genetic research study
• University of CopenhagenmajorStrategic or Co-development PartnerInternational research partner on COVID-19 GPR183 antagonism treatment research
• Australasian Leukaemia Lymphoma GroupcoreStrategic or Co-development PartnerCollaborative partner for Phase I immunotherapy clinical trial for EBV-associated Diffuse large B-cell lymphoma
• Stellenbosch UniversitymajorStrategic or Co-development PartnerSouth African university where Prof Ronacher holds appointment as Extraordinary Associate Professor; ongoing TB research collaboration
• 32 Indigenous Health ServicescoreStrategic or Co-development PartnerRepresentatives from partner health services across Queensland forming Indigenous Steering Committee for Strong Families Study
• International Association of Diabetes in Pregnancy Study GroupsmajorStrategic or Co-development PartnerGlobal organization where E/Prof McIntyre was founding member establishing GDM diagnostic criteria
• Aarhus UniversitymajorStrategic or Co-development PartnerDanish institution where E/Prof McIntyre serves as Honorary Skou Professor and Danish Diabetes Academy Visiting Professor

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Telethon Kids Institute: Western Australian child health research institute with a strong Aboriginal health research program. Mater Research's Indigenous health co-design approach and child/maternal research focus are directly comparable.
• Garvan Institute of Medical Research: Sydney-based medical research institute with programs in cancer, diabetes, neuroscience, and genomics. Mater's diabetes-in-pregnancy research (McIntyre) and neuroscience program are directly comparable to Garvan's clinical-translational focus areas.
• Children's Medical Research Institute: Sydney-based institute focused on children's health, cancer, and genetic disease research. Mater Research's mother-and-baby health focus and longitudinal cohort research are comparable in translational pediatric research orientation.
• Centenary Institute: Sydney-based medical research institute focused on cancer, cardiovascular disease, and immunology. Comparable in scale and translational research orientation, and similarly reliant on NHMRC/MRFF funding and university-hospital partnerships.
• Harry Perkins Institute of Medical Research: Western Australian medical research institute focused on cancer, cardiovascular disease, and diabetes. Comparable mid-sized translational institute competing for NHMRC funding with overlapping disease-area focus.
• Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute, focused on cancer, immunology, and infectious disease with a strong discovery-to-clinic pipeline. Mater Research is comparable in research program breadth (cancer, immunology, chronic disease) and competes for the same national competitive grant funding and biotech partnerships.
• South Australian Health and Medical Research Institute (SAHMRI): Adelaide-based flagship medical research institute with programs in cancer, heart health, and Aboriginal health. Mater Research's Indigenous health co-design model and translational research orientation make SAHMRI a comparable peer competing for the same national funding streams.
• Hudson Institute of Medical Research: Melbourne-based translational medical research institute covering cancer, reproductive health, and chronic disease. Mater Research is comparable in its translational model (co-located with hospital) and in its mother-and-baby and cancer research program mix.
• Baker Heart and Diabetes Institute: Melbourne-based institute dedicated to cardiovascular and diabetes research. Mater Research's diabetes-in-pregnancy program and chronic disease research make this a directly comparable peer in scope and translational focus.
• QIMR Berghofer Medical Research Institute: Queensland's largest medical research institute, also focused on translational biomedical research across cancer, infectious disease, and mental health. Mater Research operates in the same Brisbane-based translational medical research category and competes for the same NHMRC/MRFF funding pool and clinical trial sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PL0jT2N3aEf7uPmJ8mvf3r38AALcb94nov
• Facebookfacebook.com/materqld
• LinkedInlinkedin.com/company/mater-research
• Instagraminstagram.com/materqld
• Xx.com/MaterResearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mater Research